Iraqi Pharmacovigilance Center

Welcome to

MedSafetyWeek

MedSafetyWeek is a global campaign organized by the Iraqi Pharmacovigilance Center in collaboration with the Uppsala Monitoring Centre, along with more than 100 countries worldwide, taking place from November 3 to 9 to promote the reporting of adverse drug reactions in Iraq.

Medicines Safety Awareness

Raising awareness about the importance of reporting adverse drug reactions in Iraq.

A Global Unified Campaign

Participation of more than 100 countries in collaboration with the Uppsala Monitoring Centre.

Engagement of Health Institutions

On-ground activities and social media initiatives to promote the culture of pharmacovigilance.

What is MedSafetyWeek?

MedSafetyWeek is a global campaign organized by the Iraqi Pharmacovigilance Center, in collaboration with the Uppsala Monitoring Centre and more than 100 countries worldwide. It takes place from November 3 to 9, aiming to promote the reporting of adverse drug reactions in Iraq. The campaign includes various activities on social media and in healthcare institutions to raise awareness about the pharmacovigilance system in Iraq.

 

The Iraqi Pharmacovigilance Center, part of the Technical Affairs Directorate at the Ministry of Health, is responsible for monitoring adverse drug reactions and safety-related issues of medical products in Iraq. The center collects, analyzes, and acts upon these reports to minimize potential risks when necessary.

Alright, how can I contribute?

How can you contribute?

You can support the #MedSafetyWeek campaign by promoting medicine safety awareness and reporting any adverse drug reactions through the pharmacovigilance reporting form.

Follow all campaign updates using the hashtag #MedSafetyWeek.

Spread awareness among your family and friends about medicine safety.

Share and repost content from the official pages.

Report any side effects through the Pharmacovigilance Reporting Form.

Every report makes a difference

Access the form to document side effects and treatment-related issues.